Articles tagged "Allocation"

2020 American Transplant Congress
Effects of Mandatory 6-Month Waiting Time Policy on Post-Transplant Outcomes and Explant Pathology in Liver Transplant Patients with Hepatocellular Carcinoma
S. Nagai, T. Kitajima, S. Yeddula, R. Salgia, M. Abouljoud, D. Moonka
Henry Ford Hospital, Detroit, MI
*Purpose: In the United States, current allocation policy mandates a 6-month waiting period before exception scores are granted to liver transplant (LT) candidates with hepatocellular…
2020 American Transplant Congress
Calculating the Lung Allocation Score Error for ECMO Patients
N. Dussault¹, J. Katsis², E. Garrity¹, M. M. Churpek³, W. F. Parker¹
¹University of Chicago, Chicago, IL, ²Vanderbilt University, Nashville, TN, ³University of Wisconsin, Madision, WI
*Purpose: The use of extracorporeal membranous oxygenation (ECMO) as a bridge to lung transplantation has increased dramatically. However, the Lung Allocation Score (LAS) does not…
2020 American Transplant Congress
Concurrent Final Acceptance Associated with Decreased Deceased Donor Liver Utilization
A. Robinson¹, K. Shutterly², M. Sellers³, J. Rosendale¹, D. Brockmeier⁴
¹United Network for Organ Sharing, Richmond, VA, ²Center for Organ Recovery and Education, Pittsburgh, PA, ³Emory University Hospital and LifeLink of Georgia, Atlanta, GA, ⁴Mid-America Transplant Services, St. Louis, MO
*Purpose: With broader sharing for candidates with high MELD scores, it is not unusual for liver candidates to receive offers from multiple donors. Accepting multiple…
2020 American Transplant Congress
The New UK National Kidney Allocation Scheme with Maximized ‘D4/R4’ Kidney Transplants: Appropriate Donor to Recipient Matching or System Overstretch?
R. Pearson, E. Murray, P. Thompson, P. Mark, M. Clancy, J. Asher
Renal Transplant, Queen Elizabeth University Hospital, Glasgow, Glasgow, United Kingdom
*Purpose: The UK national deceased donor kidney matching scheme changed in September 2019, aiming to better match graft and patient survival. Donors and recipients are…
2020 American Transplant Congress
5-Year Simulated Allocation of Deceased Donor Kidneys in 3 Contiguous States within Region 3 Under the Latest 250 nm Circle Distribution Proposal
C. Warren¹, N. Battula¹, A. Zarrinpar¹, T. Kozlowski¹, M. Johnson¹, K. Andreoni²
¹University of Florida, Gainesville, FL, ²Abdominal Transplant, Surgery, University of Florida, Gainesville, FL
*Purpose: The proposed kidney allocation replaces current local and regional by a 250 nautical mile (nm) radius circle from the actual donor hospital (DH) to…
2020 American Transplant Congress
Investigating the 6-Month Effects of the UNOS Allocation System Changes on the Post Transplant Outcomes in Patients with Amyloidosis
P. Banankhah¹, G. Liu¹, J. Nattiv¹, C. Lum², A. Salimbangon³, A. Wolfson⁴, E. DePasquale¹, R. Chand⁵, P. Genyk¹, P. Kingsford¹, J. Li¹, D. Vucicevic⁶, A. Vaidya¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, S. Hashmi¹, S. Nuno¹, J. Pizula¹, D. Miklin¹, A. E. Lee¹, K. Yang¹, S. Shah¹
¹Cardiology, University of Southern California, Los Angeles, CA, ²Cardiology, The Queen's Medical Center, Honolulu, HI, ³Cardiology, UCLA Medical Center, Los Angeles, CA, ⁴Cardiology, University of Arizona Sarver Heart Center, Tucson, AZ, ⁵Cardiology, Harbor-UCLA Medical Center, Los Angeles, CA, ⁶Cardiology, Newark Beth-Israel Medical Center, Newark, NJ
*Purpose: Cardiac amyloidosis is an infiltrative cardiomyopathy with poor outcomes. Cardiac transplantation and increased utilization of mechanical support have led to improved outcomes in patients…
2020 American Transplant Congress
Comparison of Outcomes between Patients Bridged to Heart Transplantation with ECMO versus Those Not Bridged with ECMO During the Years 1985 to 2019
D. J. Miklin¹, A. D. Salimbangon², G. S. Liu¹, P. Banankhah¹, P. A. Genyk¹, P. Kingsford¹, R. R. Chand³, J. P. Li¹, D. Vucicevic⁴, A. S. Vaidya¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, J. Nattiv¹, S. Hashmi¹, S. Nuno¹, J. Pizula¹, A. E. Lee¹, K. Yang¹, S. Shaw¹, E. DePasquale¹, W. M. Aaron⁵
¹LAC-USC, Los Angeles, CA, ²UCLA Medical Center, Los Angeles, CA, ³Harbor-UCLA Medical Center, Los Angeles, CA, ⁴Newark Beth-Israel Medical Center, Newark, NJ, ⁵University of Arizona Sarver Heart Center, Tucson, AZ
*Purpose: Some patients with cardiogenic shock require extracorporeal membrane oxygenation (ECMO) for successful bridging to heart transplantation (HT). Herein, we report on the outcomes and…
2020 American Transplant Congress
Proposed New Pancreas Allocation Policy: Moving to Concentric Circles as First Unit of Allocation
A. Israni¹, S. Gustafson¹, B. Thompson¹, A. Wey¹, S. Niederhaus², R. Forbes³, A. Fox⁴, B. Kasiske¹, J. Snyder¹
¹SRTR, Minneapolis, MN, ²Univ of Maryland, Baltimore, MD, ³Vanderbilt Univ, Nashville, TN, ⁴UNOS, Richmond, VA
*Purpose: The Organ Procurement and Transplantation Network (OPTN) proposed a new national deceased donor pancreas allocation policy that removes donor service area and OPTN region…
2020 American Transplant Congress
Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region
B. F. Goudsmit¹, H. Putter², B. Van Hoek³, A. E. Braat¹
¹Transplantation Surgery, Leiden University Medical Center, Leiden, Netherlands, ²Biostatistics, Leiden University Medical Center, Leiden, Netherlands, ³Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
*Purpose: The shortage of liver grafts results in the prioritization of the sickest patients on the waiting list for liver transplantation. Since 2006, the degree…
2020 American Transplant Congress
Is Dual Allocation Successful at Higher Remuzzi Scores? Outcomes of Dual Kidney Transplants at Remuzzi Scores of 8 or Greater
V. Fleetwood¹, C. Kensinger², C. Papageorge¹, D. Aufhauser¹, G. Leverson³, B. Welch¹, D. Foley¹, P. Pasha¹
¹Department of Transplantation, University of Wisconsin, Madison, WI, ²Department of Transplantation, Piedmont Transplant Center, Atlanta, GA, ³Department of Statistics, University of Wisconsin, Madison, WI
*Purpose: The Remuzzi score (RS) is a histologic assessment of donor kidneys based on degree of glomerulosclerosis, arterial narrowing, interstitial fibrosis, and tubular atrophy. The…